Business OperationsThe company announced that it is ceasing all HBV drug discovery efforts, which will result in a workforce reduction of 40%.
Financial PerformanceThe company will take a one-time restructuring charge of ~$3-4M.
Legal IssuesThe case against Moderna remains on track for an April 21, 2025 trial date, with expert depositions and reports the next steps.